Free audit · No signup
Tool Sprawl Risk Audit — Pharmaceuticals
Find out how much spreadsheet and SaaS sprawl is costing Pharmaceuticals — and where a purpose-built internal tool pays off.
Signs of tool sprawl in Pharmaceuticals
- Clinical trial recruitment runs 30-50% behind plan; site activation takes 8-12 months and patient screening is manual chart review.
- Regulatory submissions (NDA, BLA, MAA) are coordinated across dozens of CROs, sites, and writers via SharePoint and version-numbered Word documents.
- Pharmacovigilance case intake is drowning in adverse-event reports; medical reviewers spend nights triaging individual case safety reports.
- GxP validation requirements turn every IT change into a six-month project; cloud and SaaS adoption lags every other regulated industry.
Source of Truth
Whether your operational data lives in one place or is scattered across tools.
More tools for Pharmaceuticals
AI Readiness Audit
Score process clarity, data readiness, team adoption, and guardrails before investing in AI.
Sample output
67/100 → pilot with control, not full rollout
Digital Transformation Audit
Assess KPI clarity, reporting, tool alignment, ownership, and automation maturity.
Sample output
52/100 → foundation gaps in metrics and handoffs
Cost of Manual Work — Pharmaceuticals
Quantify the annual cost and people-weeks lost to repetitive manual work — and the automation payback.
Build vs Buy — Pharmaceuticals
Compare the multi-year total cost of SaaS subscriptions against a custom build — with a clear build, buy, or hybrid recommendation.
Revenue Leak — Pharmaceuticals
See how much revenue leaks every month from a low conversion rate — and what closing the gap to your target is worth.
AI Readiness Audit — Pharmaceuticals
Score whether your team has the strategy, data, process, and guardrails to deploy practical AI — framed around the highest-ROI use cases for your sector.